Pesquisas alternativas:
came » case (Expandir a Pesquisa), care (Expandir a Pesquisa), come (Expandir a Pesquisa)
name » nam (Expandir a Pesquisa)
none » non (Expandir a Pesquisa)
came » case (Expandir a Pesquisa), care (Expandir a Pesquisa), come (Expandir a Pesquisa)
name » nam (Expandir a Pesquisa)
none » non (Expandir a Pesquisa)
1
“... contained a standardized vocabulary concept. For Wisconsin, none of the incoming ELR messages contained a...”
Obter o texto integral
Obter o texto integral
Artigo
2
Por Scaffidi, M A, Li, J, Khan, R, Gimpaya, N, Pivetta, B, Grover, S C
Publicado no J Can Assoc Gastroenterol (2019)
“... companies making biologic medications for IBD among contributors to UpToDate articles on the treatment...”Publicado no J Can Assoc Gastroenterol (2019)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Schroeder, Scott R, Salomon, Meghan M, Galanter, William L, Schiff, Gordon D, Vaida, Allen J, Gaunt, Michael J, Bryson, Michelle L, Rash, Christine, Falck, Suzanne, Lambert, Bruce L
Publicado no BMJ Qual Saf (2017)
“...BACKGROUND: Drug name confusion is a common type of medication error and a persistent threat...”Publicado no BMJ Qual Saf (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Perković, I., Butula, I., Kralj, M., Martin-Kleiner, I., Balzarini, J., Hadjipavlou-Litina, D., Katsori, A.-M., Zorc, B.
Publicado no Eur J Med Chem (2012)
“...). None of the compounds were inhibitory to a broad panel of DNA and RNA viruses in the cell culture...”Publicado no Eur J Med Chem (2012)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“... associated with these cytotoxic agents. nab-paclitaxel is a solvent free, albumin-bound 130-nanometer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Blomstrand, Hakon, Scheibling, Ursula, Bratthäll, Charlotte, Green, Henrik, Elander, Nils O.
Publicado no BMC Cancer (2019)
“... (Gem/NabP) showed increased overall survival compared to gemcitabine alone in the treatment of advanced...”Publicado no BMC Cancer (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Ozaki, Daniel A., Gao, Hongmei, Todd, Christopher A., Greene, Kelli M., Montefiori, David C., Sarzotti-Kelsoe, Marcella
Publicado em 2012
“... compliance. Furthermore, using a newly established external proficiency testing program for the TZM-bl NAb...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Dranitsaris, George, Yu, Bo, King, Jennifer, Kaura, Satyin, Zhang, Adams
Publicado no Clinicoecon Outcomes Res (2015)
“... for the key stakeholders, a cost-utility analysis comparing nab-paclitaxel to docetaxel, both as alternatives...”Publicado no Clinicoecon Outcomes Res (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... of 2020 resulted in a significant reduction in the community transmission of the COVID-19 pandemic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
11
Por Chen, Yi, Li, Jinyu, Chen, Shixue, Zhang, Yibao, Hu, Yi, Zhang, Guoqing, Yan, Xiang, Jiao, Shunchang
Publicado no Sci Rep (2017)
“...-PC and docetaxel remained unclear until now. This retrospective study aimed to compare the efficacy...”Publicado no Sci Rep (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Wang, Jianfu J., Zhang, Nan, Richardson, Sarah A., Wu, Jin V.
Publicado no Expert Rev Mol Diagn (2021)
“... of POCTs have been developed and are commercially available now. They are designed to detect either a SARS...”Publicado no Expert Rev Mol Diagn (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Haas, Eric J, Angulo, Frederick J, McLaughlin, John M, Anis, Emilia, Singer, Shepherd R, Khan, Farid, Brooks, Nati, Smaja, Meir, Mircus, Gabriel, Pan, Kaijie, Southern, Jo, Swerdlow, David L, Jodar, Luis, Levy, Yeheskel, Alroy-Preis, Sharon
Publicado no Lancet (2021)
“... BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Health (MoH...”Publicado no Lancet (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Kawamoto, Yasuyuki, Komatsu, Yoshito, Yuki, Satoshi, Sawada, Kentaro, Muranaka, Tetsuhito, Harada, Kazuaki, Nakatsumi, Hiroshi, Fukushima, Hiraku, Ishiguro, Atsushi, Dazai, Masayoshi, Hatanaka, Kazuteru, Nakamura, Michio, Iwanaga, Ichiro, Uebayashi, Minoru, Sogabe, Susumu, Kobayashi, Yoshimitsu, Miyagishima, Takuto, Ono, Kota, Sakamoto, Naoya, Sakata, Yuh
Publicado no BMC Cancer (2017)
“... with advanced gastric cancer. Moreover, the S-1 plus oxaliplatin regimen is now a standard treatment. Nab...”Publicado no BMC Cancer (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Shaban, Warda M., Rabie, Asmaa H., Saleh, Ahmed I., Abo-Elsoud, M.A.
Publicado no Knowl Based Syst (2020)
“...COVID-19 infection is growing in a rapid rate. Due to unavailability of specific drugs, early...”Publicado no Knowl Based Syst (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell...
Por Zhang, Fan, Huang, Di, Zhao, Lei, Li, Tao, Zhang, Sujie, Zhang, Guoqing, Yuan, Fang, Zhang, Jie, Zhang, Yuzi, Zhao, Zhengyi, Cui, Longgang, Zhao, Jing, Wang, Guoqiang, Cai, Shangli, Bai, Yuezong, Wang, Jinliang, Hu, Yi
Publicado no Ther Adv Med Oncol (2020)
“... with anti-PD-1/PD-L1 monotherapy and 17 were treated with anti-PD-1/PD-L1 plus nab-paclitaxel. With a median...”Publicado no Ther Adv Med Oncol (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Oguntuyo, Kasopefoluwa Y., Stevens, Christian S., Hung, Chuan-Tien, Ikegame, Satoshi, Acklin, Joshua A., Kowdle, Shreyas S., Carmichael, Jillian C., Chiu, Hsin-Ping, Azarm, Kristopher D., Haas, Griffin D., Amanat, Fatima, Klingler, Jéromine, Baine, Ian, Arinsburg, Suzanne, Bandres, Juan C., Siddiquey, Mohammed N.A., Schilke, Robert M., Woolard, Matthew D., Zhang, Hongbo, Duty, Andrew J., Kraus, Thomas A., Moran, Thomas M., Tortorella, Domenico, Lim, Jean K., Gamarnik, Andrea V., Hioe, Catarina E., Zolla-Pazner, Susan, Ivanov, Stanimir S., Kamil, Jeremy P., Krammer, Florian, Lee, Benhur
Publicado no medRxiv (2020)
“... neutralizing antibodies (nAbs) against the SARS-CoV-2 spike glycoprotein (CoV2-S). However, rigorous efficacy...”Publicado no medRxiv (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Aziz, Peshawa Yunis, Hadi, Jihad M., Sha, Aram M., Aziz, Shujahadeen Bakr, Rahman, Heshu Sulaiman, Ahmed, Hiwa A., Abdulla, Mahmood Ameen, Amine Ali, Shwan M.
Publicado no International Journal of Surgery Open (2020)
“... to the patients' strong immune systems, since none of them had a history of using alcohol and drugs, or of chronic...”Publicado no International Journal of Surgery Open (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Hutchinson, Jennie M., Mesa, Kathryn A., Alexander, David L., Yu, Bin, O'Rourke, Sara M., Limoli, Kay L., Wrin, Terri, Deeks, Steven G., Berman, Phillip W.
Publicado no Front Immunol (2019)
“... recovered from these individuals may more closely resemble the Envs that gave rise to bNAbs compared...”Publicado no Front Immunol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16...
Por Einstein, Mark H, Baron, Mira, Levin, Myron J, Chatterjee, Archana, Fox, Bradley, Scholar, Sofia, Rosen, Jeffrey, Chakhtoura, Nahida, Meric, Dorothée, Dessy, Francis J, Datta, Sanjoy K, Descamps, Dominique, Dubin, Gary
Publicado em 2011
“...). Month 7 results were previously reported; we now report Month 24 results. In the according-to-protocol...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo